- Home
- RVMD vs CR Comparison
RVMD vs CR Comparison
Compare RVMD & CR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- CR
- Stock Information
- Founded
- RVMD 2014
- CR 1855
- Country
- RVMD United States
- CR United States
- Employees
- RVMD N/A
- CR N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- CR Metal Fabrications
- Sector
- RVMD Health Care
- CR Industrials
- Exchange
- RVMD Nasdaq
- CR Nasdaq
- Market Cap
- RVMD 8.7B
- CR 8.9B
- IPO Year
- RVMD 2020
- CR N/A
- Fundamental
- Price
- RVMD $37.29
- CR $152.08
- Analyst Decision
- RVMD Strong Buy
- CR Strong Buy
- Analyst Count
- RVMD 13
- CR 6
- Target Price
- RVMD $67.77
- CR $174.80
- AVG Volume (30 Days)
- RVMD 1.3M
- CR 382.5K
- Earning Date
- RVMD 05-07-2025
- CR 04-21-2025
- Dividend Yield
- RVMD N/A
- CR 0.61%
- EPS Growth
- RVMD N/A
- CR 13.55
- EPS
- RVMD N/A
- CR 5.05
- Revenue
- RVMD N/A
- CR $2,131,200,000.00
- Revenue This Year
- RVMD N/A
- CR $9.28
- Revenue Next Year
- RVMD $153.09
- CR $6.57
- P/E Ratio
- RVMD N/A
- CR $33.05
- Revenue Growth
- RVMD N/A
- CR 14.45
- 52 Week Low
- RVMD $29.55
- CR $128.50
- 52 Week High
- RVMD $62.40
- CR $188.52
- Technical
- Relative Strength Index (RSI)
- RVMD 42.92
- CR 42.29
- Support Level
- RVMD $37.42
- CR $150.41
- Resistance Level
- RVMD $39.59
- CR $161.47
- Average True Range (ATR)
- RVMD 1.32
- CR 4.39
- MACD
- RVMD 0.05
- CR 0.45
- Stochastic Oscillator
- RVMD 29.10
- CR 21.87
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.